WeedMD and Blockstrain Pilot a Proprietary Genome Tracking Program to Protect Cannabis Genetics & Intellectual Property
WeedMD Launches Blockstrain’s Revolutionary ‘Genome-to-Sale’ Software Toronto, Canada, October 24, 2018 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, and Blockstrain Technology Corp. (TSXV:DNAX.V) (OTC:DNAXF) (“Blockstrain”) are pleased to announce that they have kicked off the...
